William J. Peters - 30 Jun 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Issuer symbol
AMPH
Transactions as of
30 Jun 2022
Net transactions value
-$367,720
Form type
4
Filing time
01 Jul 2022, 18:08:35 UTC
Previous filing
22 Jun 2022
Next filing
10 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $274,871 +18,386 +18% $14.95 118,866 30 Jun 2022 Direct
transaction AMPH Common Stock Sale $642,591 -18,386 -15% $34.95 100,480 30 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -18,386 -73% $0.000000 6,688 30 Jun 2022 Common Stock 18,386 $14.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022.
F2 Shares subject to the option are fully vested and immediately exercisable.